SCHEMBL174449

SCHEMBL174449

O=C(O)c1ccc(-c2ccc3cc(O)c([C]4CCCCCCC4)cc3c2)cc1.[CH2].[CH2]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
THRB P10828 1/20 0.51
RECQL P46063 1/20 0.51
NR2E1 Q9Y466 1/20 0.51
RARB P10826 11/20 0.49
RARG P13631 11/20 0.49
RARA P10276 9/20 0.49
ERN1 O75460 2/20 0.45
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 2/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL16147145 0.97 MEN1 (0.51) MEN1KMT2ATHRBRECQLNR2E1
Methane SCHEMBL16147650 0.84 RARB (0.56) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL1250065 0.75 ACMSD (0.57) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL14157072 0.72 MIF (0.57) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL5047765 0.72 RARB (0.60) MEN1KMT2ARARBRARGRARA
Methane SCHEMBL16146729 0.72 RARB (0.60) MEN1KMT2ARARBRARGRARA
SCHEMBL3020401 0.71 ESR1 (0.67) MEN1KMT2ARARBRARGRARA
SCHEMBL20979999 0.70 MEN1 (0.57) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL30526912 0.70 RARB (0.62) MEN1KMT2ARARBRARGRARA
SCHEMBL29049592 0.70 RARB (0.62) MEN1KMT2ARARBRARGRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3638209-A1 NANOPARTICLE COMPOSITIONS, METHODS OF FABRICATION, AND USE FOR DRUG DELIVERY Dignity Health (US) 2020-04-22 EP disclosed
WO-2018232366-A1 NANOPARTICLE COMPOSITIONS, METHODS OF FABRICATION, AND USE FOR DRUG DELIVERY DIGNITY HEALTH (US) 2018-12-20 WO disclosed
EP-3393481-A1 OIL-IN-WATER EMULSIONS INCLUDING RETINOIC ACID NOVARTIS AG (CH) 2018-10-31 EP disclosed
WO-2017192606-A1 METHODS OF PRODUCING SPECIALIZED CARDIO-LIKE CELLS FROM STEM CELL EMORY UNIVERSITY (US) 2017-11-09 WO disclosed
WO-2017108902-A1 OIL-IN-WATER EMULSIONS INCLUDING RETINOIC ACID NOVARTIS AG (CH) 2017-06-29 WO disclosed
EP-2613776-A2 COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION Thomas Jefferson University (US) 2013-07-17 EP disclosed
WO-2012030919-A2 COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION THOMAS JEFFERSON UNIVERSITY (US) 2012-03-08 WO disclosed